Journal of Rheumatic Diseases

Scope & Guideline

Fostering collaboration to transform rheumatology insights.

Introduction

Explore the comprehensive scope of Journal of Rheumatic Diseases through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore Journal of Rheumatic Diseases in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN2093-940x
PublisherKOREAN COLL RHEUMATOLOGY
Support Open AccessYes
CountrySouth Korea
TypeJournal
Convergefrom 2019 to 2024
AbbreviationJ RHEUMAT DIS / J. Rheum. Dis.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressRAEMIAN YONGSAN A BLDG 1917, 95 HANGANG-DAERO, YONGSAN-GU, SEOUL 04378, SOUTH KOREA

Aims and Scopes

The Journal of Rheumatic Diseases focuses on advancing knowledge in rheumatology through original research, reviews, and case reports. It aims to address various aspects of rheumatic diseases, including their epidemiology, pathophysiology, diagnosis, treatment, and patient outcomes.
  1. Clinical Research in Rheumatology:
    The journal publishes studies that explore the clinical characteristics, treatment responses, and outcomes of patients with various rheumatic diseases, contributing valuable data to the field.
  2. Innovative Therapeutic Approaches:
    A significant emphasis is placed on research involving new therapeutic strategies, including biologics, disease-modifying antirheumatic drugs (DMARDs), and emerging treatments for rheumatic conditions.
  3. Epidemiology and Disease Patterns:
    The journal includes epidemiological studies that investigate the prevalence, risk factors, and demographic characteristics of rheumatic diseases, particularly within specific populations.
  4. Pathophysiology and Mechanistic Studies:
    Research delving into the underlying biological mechanisms of rheumatic diseases, including genetic, immunological, and environmental factors, is a key focus area.
  5. Patient-Centered Outcomes and Quality of Life:
    The journal highlights studies that assess patient-reported outcomes, quality of life, and the psychosocial aspects of living with rheumatic diseases.
  6. Multidisciplinary Approaches:
    The journal recognizes the importance of multidisciplinary care in rheumatology, encouraging submissions that explore collaborations between rheumatologists, physiotherapists, and other healthcare providers.
Recent publications in the Journal of Rheumatic Diseases indicate a shift towards emerging themes that reflect current trends in rheumatology research. These themes are increasingly relevant to contemporary clinical practice and patient management.
  1. Biologics and Targeted Therapies:
    There is a growing body of research focusing on the effectiveness and safety of biologic therapies in various rheumatic diseases, indicating a trend towards personalized medicine and tailored treatment strategies.
  2. Impact of COVID-19 on Rheumatic Diseases:
    Research examining the implications of COVID-19 on patients with rheumatic diseases, including vaccination responses and disease management during the pandemic, has surged, reflecting the ongoing relevance of this global health crisis.
  3. Machine Learning and Predictive Analytics:
    The application of machine learning models and predictive analytics in rheumatology to forecast disease progression and treatment outcomes is emerging as a significant theme, showcasing the integration of technology in clinical practice.
  4. Patient Education and Empowerment:
    Studies emphasizing the importance of patient education, self-management, and shared decision-making in the management of rheumatic diseases are increasingly featured, highlighting a shift towards patient-centered care.
  5. Long-term Outcomes and Quality of Life Assessments:
    Research focusing on long-term outcomes, including renal prognosis and quality of life in patients with chronic rheumatic diseases, is becoming more prominent, reflecting a holistic approach to patient care.

Declining or Waning

While the Journal of Rheumatic Diseases has consistently focused on several core themes, some areas of research have shown a decline in prominence over the recent years, reflecting shifts in clinical interest and advancements in the field.
  1. Traditional Treatments and Conventional Therapies:
    Research focused solely on traditional DMARDs and older treatment modalities has decreased, likely due to the rise of biologics and targeted therapies, which are becoming the standard of care.
  2. Basic Science without Clinical Relevance:
    Studies that explore basic science aspects of rheumatology without a clear clinical application or relevance have become less frequent, as the journal aims to prioritize research that directly impacts patient care.
  3. Single-Center Studies:
    The prevalence of single-center studies has decreased as the journal favors larger, multi-center studies that provide more robust data and generalizability of findings.
  4. Non-Interventional Observational Studies:
    There appears to be a waning interest in non-interventional observational studies that do not offer new insights into treatment efficacy or patient outcomes, as the field moves towards more rigorous interventional research.

Similar Journals

Modern Rheumatology

Empowering Professionals Through Cutting-Edge Research
Publisher: OXFORD UNIV PRESSISSN: 1439-7595Frequency: 6 issues/year

Modern Rheumatology is a premier journal dedicated to advancing the field of rheumatology through high-quality peer-reviewed research. Published by Oxford University Press, this journal reflects the latest developments in rheumatologic medicine, catering to researchers, clinicians, and students alike. With an H-Index highlighting its scholarly impact, Modern Rheumatology occupies a notable position, ranking Q2 in both the fields of Medicine and Rheumatology in 2023, and is listed among the top 25 journals in its category by Scopus. Spanning from the year 2000 to 2024, the journal features a diverse array of topics aimed at addressing current challenges and innovations in the field. Although it does not offer Open Access, it provides essential insights for professionals seeking to stay abreast of evolving treatment modalities and research breakthroughs. Located in the heart of the United Kingdom, Modern Rheumatology is a vital resource for anyone committed to enhancing the understanding and treatment of rheumatic diseases.

Current Rheumatology Reviews

Advancing knowledge in rheumatology.
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1573-3971Frequency: 3 issues/year

Current Rheumatology Reviews is an esteemed journal dedicated to publishing comprehensive reviews on advancements in the field of rheumatology. Established by Bentham Science Publishers, this journal has become a vital resource for researchers, clinicians, and students seeking to stay abreast of the latest developments and therapeutic strategies from 2006 to 2024. Located in the United Arab Emirates, it caters to a global audience, delivering insights that have been pivotal in shaping clinical practices. With an impact factor reflective of its Q3 status in Rheumatology by 2023, the journal ranks #46 out of 73 in the Scopus database, positioning it in the 37th percentile in the discipline. Although it operates without open access, its high-quality content ensures that each article undergoes rigorous peer review, making the Current Rheumatology Reviews a trusted platform for disseminating critical research findings and reviews that drive forward the understanding and treatment of rheumatic diseases.

Lancet Rheumatology

Elevating the discourse in rheumatology and immunology.
Publisher: ELSEVIERISSN: 2665-9913Frequency: 12 issues/year

The Lancet Rheumatology, published by Elsevier, is a premier academic journal dedicated to advancing the understanding of rheumatology and immunological diseases. Launched in 2019, this esteemed publication has quickly become a leading source of research, achieving an impressive Q1 ranking in both the fields of Rheumatology and Immunology as of 2023. With Scopus rankings placing it at #2 out of 73 in Medicine - Rheumatology and #6 out of 233 in Medicine - Immunology and Allergy, the journal serves as an essential platform for disseminating high-quality, peer-reviewed articles that address the latest findings and clinical practices in these domains. The journal, accessible in print and online, is committed to fostering knowledge and collaboration among researchers, healthcare professionals, and students alike, making it an invaluable resource for those seeking to deepen their expertise in rheumatology and its interrelated fields.

Reumatologia

Advancing knowledge in Rheumatology and Immunology.
Publisher: TERMEDIA PUBLISHING HOUSE LTDISSN: 0034-6233Frequency: 6 issues/year

Reumatologia is a dedicated open-access journal published by TERMEDIA PUBLISHING HOUSE LTD that has been serving the global scientific community since 2005. The journal focuses on the fields of Rheumatology, Immunology, and Allergy, providing a rich platform for researchers and practitioners to share innovative findings, clinical insights, and methodologies. With its roots tracing back to the early 1960s and a steady convergence of quality content through 2024, Reumatologia has secured a place in the academic landscape, currently holding a Q4 rating in Immunology and a Q3 rating in both Immunology and Allergy and Rheumatology categories for 2023. While the journal ranks #42 out of 73 in the Medicine - Rheumatology category, its open-access model ensures that research is widely disseminated, enhancing visibility and accessibility to vital knowledge that shapes therapeutic practices. Located in Poznan, Poland, Reumatologia remains a pivotal source of credible research, fostering collaboration among academics, healthcare professionals, and students internationally.

SEMINARS IN ARTHRITIS AND RHEUMATISM

Fostering breakthroughs in arthritis research since 1971.
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 0049-0172Frequency: 6 issues/year

SEMINARS IN ARTHRITIS AND RHEUMATISM, published by W B Saunders Co-Elsevier Inc, is a leading journal in the fields of rheumatology and pain medicine. With an impressive impact factor and recognized as a Q1 journal in both its categories, it ranks #8 in Anesthesiology and Pain Medicine and #11 in Rheumatology based on the latest Scopus data, placing it within the top echelons of academic research. Established in 1971, this esteemed publication offers a comprehensive platform for researchers and practitioners to disseminate and engage with cutting-edge studies that advance the understanding and treatment of arthritis and related conditions. With its robust editorial process and focus on high-quality, peer-reviewed articles, the journal not only contributes to scientific knowledge but also serves as an essential resource for professionals and students seeking contemporary insights into effective management strategies and emerging therapies in the rheumatologic field. Although it does not offer open access, its subscription model ensures a wide distribution among academic and clinical institutions, reinforcing its significance in the research community.

Reumatismo

Unveiling breakthroughs in rheumatic disease management.
Publisher: PAGEPRESS PUBLISSN: 0048-7449Frequency: 4 issues/year

Reumatismo is a distinguished Open Access journal dedicated to the field of rheumatology, published by PAGEPRESS PUBL since 2001. With a rich history dating back to 1952, this journal has been pivotal in disseminating vital research on rheumatic diseases and related disorders. Based in Italy, Reumatismo has earned a reputation for its quality and relevance, achieving a Q3 category ranking in the 2023 Scopus metrics for Rheumatology, reflecting its significant contributions to the field. The journal is committed to providing a platform for the latest scientific developments and clinical innovations, thus aiding researchers, healthcare professionals, and students striving to enhance understanding and treatment of rheumatic conditions. For those seeking to access comprehensive research articles and studies, Reumatismo boasts an open access policy, ensuring that knowledge is freely available to all, fostering collaboration and advancement in rheumatology worldwide.

Indian Journal of Rheumatology

Exploring the frontiers of rheumatologic care and research.
Publisher: SAGE PUBLICATIONS INCISSN: 0973-3698Frequency: 4 issues/year

Welcome to the Indian Journal of Rheumatology, a premier scholarly platform dedicated to advancing research and clinical practice in the field of rheumatology. Published by SAGE Publications Inc., this journal has been providing open access to its valuable content since 2006, promoting the dissemination of knowledge in India and beyond. As a voice in the rheumatology community, the journal addresses a wide range of topics including epidemiology, diagnostics, treatment strategies, and patient care in rheumatic diseases. Despite being classified in the Q4 category of the 2023 Scopus rankings, with a current position of Rank #57 among 73 journals, it serves as an essential resource for researchers, healthcare professionals, and students seeking to stay updated with the latest developments. The journal is committed to fostering scholarly dialogue and facilitating access to research that influences practice and improves patient outcomes in rheumatologic care.

Lupus Science & Medicine

Advancing lupus research for a healthier tomorrow.
Publisher: BMJ PUBLISHING GROUPISSN: 2053-8790Frequency: 1 issue/year

Lupus Science & Medicine is a leading open-access journal published by the BMJ Publishing Group, dedicated to advancing the understanding and treatment of lupus and related autoimmune diseases. Since its establishment in 2014, the journal has fostered an academic environment for researchers, healthcare professionals, and students, providing a platform for high-quality, evidence-based studies. With a notable impact in the fields of immunology and rheumatology, it currently holds a Q1 ranking in Rheumatology and Medicine (miscellaneous) and Q2 in Immunology, reflecting its significant contribution to these vital areas of medical research. The journal is indexed in Scopus, with a commendable rank in the 67th percentile for Rheumatology, making it a valuable resource for those seeking the latest insights into lupus management and treatment. The journal emphasizes the importance of open access, ensuring that research findings are widely available to enhance global knowledge and collaboration in the fight against lupus.

Pediatric Rheumatology

Connecting global experts to elevate pediatric health research.
Publisher: BMCISSN: Frequency: 1 issue/year

Pediatric Rheumatology is a leading peer-reviewed open access journal published by BMC, dedicated to disseminating high-quality research in the field of pediatric rheumatology. Since its inception in 2007, the journal has established itself as a vital resource for healthcare professionals, researchers, and students focused on pediatric immunology, rheumatology, and child health, maintaining an impressive Q1 ranking in Pediatrics and Q2 in Immunology and Allergy as well as Rheumatology for 2023. It is recognized for its impact on advancing knowledge and clinical practice, with significant contributions noted in various studies and case reports. With access options that embrace the ethos of open science, all articles published in Pediatric Rheumatology are freely available, promoting collaborative research and discussion among practitioners across the globe. The journal welcomes submissions that encapsulate innovative research, clinical trials, and reviews that address both current challenges and advancements within the pediatric rheumatology landscape.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY

Advancing knowledge in rheumatology and immunology.
Publisher: CLINICAL & EXPER RHEUMATOLOGYISSN: 0392-856XFrequency: 6 issues/year

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY is a prestigious journal published by CLINICAL & EXPER RHEUMATOLOGY, dedicated to advancing the field of rheumatology and immunology. With a rich history dating back to 1983, the journal serves as a critical platform for researchers, clinicians, and professionals seeking to disseminate and discuss innovative findings in these rapidly evolving areas. Featuring an impressive Q2 ranking in both Immunology and Allergy, as well as Rheumatology, this journal is recognized for its high-quality contributions, placing it among the top tier of academic publications. Operating without an open access model, CLINICAL AND EXPERIMENTAL RHEUMATOLOGY is headquartered in Pisa, Italy, and publishes articles that undergo rigorous peer review to ensure excellence in research. This journal is an invaluable resource for those dedicated to improving patient outcomes through evidence-based practice in rheumatology, immunology, and related fields.